Harvard Interest Expense from 2010 to 2024

HBIO Stock  USD 2.20  0.01  0.46%   
Harvard Bioscience Interest Expense yearly trend continues to be very stable with very little volatility. Interest Expense is likely to grow to about 3.8 M this year. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2000-03-31
Previous Quarter
749 K
Current Value
856 K
Quarterly Volatility
34.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harvard Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harvard Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.3 M, Interest Expense of 3.8 M or Total Revenue of 96.8 M, as well as many indicators such as Price To Sales Ratio of 1.72, Dividend Yield of 0.0022 or PTB Ratio of 4.65. Harvard financial statements analysis is a perfect complement when working with Harvard Bioscience Valuation or Volatility modules.
  
Check out the analysis of Harvard Bioscience Correlation against competitors.
To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.

Latest Harvard Bioscience's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Harvard Bioscience over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Harvard Bioscience's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harvard Bioscience's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

Harvard Interest Expense Regression Statistics

Arithmetic Mean2,149,703
Geometric Mean0.00
Coefficient Of Variation88.85
Mean Deviation1,642,311
Median990,000
Standard Deviation1,909,936
Sample Variance3.6T
Range5.4M
R-Value0.66
Mean Square Error2.2T
R-Squared0.44
Significance0.01
Slope283,707
Total Sum of Squares51.1T

Harvard Interest Expense History

20243.8 M
20233.6 M
20222.2 M
20211.5 M
20204.8 M
20195.4 M
20185.4 M

About Harvard Bioscience Financial Statements

Harvard Bioscience investors utilize fundamental indicators, such as Interest Expense, to predict how Harvard Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Interest Expense3.6 M3.8 M
When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:
Check out the analysis of Harvard Bioscience Correlation against competitors.
To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Earnings Share
(0.33)
Revenue Per Share
2.258
Quarterly Revenue Growth
(0.13)
Return On Assets
(0.02)
The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.